Riskpilot← Back to searchSign inGet full accessHolmlund Medical AB
ABActiveOrg 5567632863Nytorgsgatan 14General medical practice activities · NACE 8621Est. 20081 employees
Revenue 2024
SEK 678K
-18% vs 2023
EBITDA margin
72.0%
-9% vs 2023
Equity ratio
96.5%
Financial strength
Net profit 2024
SEK 329K
-65% vs 2023
| Revenue | SEK 678K | -18% |
| EBITDA | SEK 489K | -9% |
| Net profit | SEK 329K | -65% |
| Total assets | SEK 4,7M | +2% |
| Equity | SEK 4,6M | +3% |
| Employees | 1 | — |
Legal name
Holmlund Medical AB
Org number
5567632863
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 augusti 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tjänster inom sjuk- och hälsovård, rehabilitering och utbildningsverksamhet, förvaltning av värdepapper samt därmed förenlig verksamhet. Bolaget skall därtill idka uthyrning av entreprenadmaskiner samt därmed förenlig verksamhet.
Address
Nytorgsgatan 14
Phone
+46702197952
Email
tobbeholmlund@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 813 | 614 | 532 | 831 | 678 |
| Staff expenses | — | — | — | — | −40 |
| EBITDA | 401 | 192 | 638 | 534 | 489 |
| Depreciation & amort. | −37 | −95 | −56 | −158 | −166 |
| EBIT | 364 | 97 | 582 | 376 | 322 |
| Net financials | 98 | 3 519 | 45 | 810 | 93 |
| Profit before tax | 462 | 3 616 | 626 | 1 185 | 416 |
| Tax | −83 | −29 | −131 | −244 | −87 |
| Net profit | 379 | 3 587 | 495 | 941 | 329 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 887 | 5 417 | 5 780 | 4 622 | 4 737 |
| Equity | 1 841 | 5 244 | 5 551 | 4 447 | 4 572 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 46 | 173 | 228 | 174 | 165 |
| Total debt | 46 | 173 | 228 | 174 | 165 |
EBITDA margin
72.0%
This company
15.8%
Market median
+356% vs market
20202024
Equity ratio
96.5%
This company
38.2%
Market median
+153% vs market
20202024
Return on equity
7.2%
This company
18.4%
Market median
-61% vs market
20202024
Net profit margin
48.5%
This company
8.1%
Market median
+499% vs market
20202024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LG Audit | Audit | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Holmlund Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gösta Ekeståhl | Audit | 0 companies |
| Karin Lena Elisabeth Holmlund | Deputy Board Member | 0 companies |
| Erik Olof Thorbjörn Holmlund | Board of Directors | 0 companies |